248 related articles for article (PubMed ID: 21226903)
41. Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma.
Gödeke J; Luxenburger E; Trippel F; Becker K; Häberle B; Müller-Höcker J; von Schweinitz D; Kappler R
Hepatol Int; 2016 Mar; 10(2):370-6. PubMed ID: 26646663
[TBL] [Abstract][Full Text] [Related]
42. Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer.
Hu W; Fan C; Jiang P; Ma Z; Yan X; Di S; Jiang S; Li T; Cheng Y; Yang Y
Oncotarget; 2016 Jan; 7(1):209-23. PubMed ID: 26506239
[TBL] [Abstract][Full Text] [Related]
43. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.
Lee DC; Kang YK; Kim WH; Jang YJ; Kim DJ; Park IY; Sohn BH; Sohn HA; Lee HG; Lim JS; Kim JW; Song EY; Kim DM; Lee MN; Oh GT; Kim SJ; Park KC; Yoo HS; Choi JY; Yeom YI
Cancer Res; 2008 Jun; 68(11):4210-20. PubMed ID: 18519680
[TBL] [Abstract][Full Text] [Related]
44. NDRG2 controls COX-2/PGE₂-mediated breast cancer cell migration and invasion.
Kim MJ; Kim HS; Lee SH; Yang Y; Lee MS; Lim JS
Mol Cells; 2014 Oct; 37(10):759-65. PubMed ID: 25256221
[TBL] [Abstract][Full Text] [Related]
45. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer.
Yamamura A; Miura K; Karasawa H; Morishita K; Abe K; Mizuguchi Y; Saiki Y; Fukushige S; Kaneko N; Sase T; Nagase H; Sunamura M; Motoi F; Egawa S; Shibata C; Unno M; Sasaki I; Horii A
Biochem Biophys Res Commun; 2013 Nov; 441(1):102-7. PubMed ID: 24134849
[TBL] [Abstract][Full Text] [Related]
46. NDRG2 correlated with favorable recurrence-free survival inhibits metastasis of mouse breast cancer cells via attenuation of active TGF-β production.
Oh SS; Kim D; Kim DH; Chang HH; Sohn KC; Kim KH; Jung SH; Lee BK; Kim JH; Kim KD
Carcinogenesis; 2012 Oct; 33(10):1882-8. PubMed ID: 22696597
[TBL] [Abstract][Full Text] [Related]
47. The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome.
Butt AJ; Sergio CM; Inman CK; Anderson LR; McNeil CM; Russell AJ; Nousch M; Preiss T; Biankin AV; Sutherland RL; Musgrove EA
Breast Cancer Res; 2008; 10(2):R28. PubMed ID: 18373870
[TBL] [Abstract][Full Text] [Related]
48. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
49. Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death.
Choi SC; Yoon SR; Park YP; Song EY; Kim JW; Kim WH; Yang Y; Lim JS; Lee HG
Exp Mol Med; 2007 Dec; 39(6):705-14. PubMed ID: 18160841
[TBL] [Abstract][Full Text] [Related]
50. Identification of downstream targets of estrogen and c-myc in breast cancer cells.
Musgrove EA; Sergio CM; Anderson LR; Inman CK; McNeil CM; Alles MC; Gardiner-Garden M; Ormandy CJ; Butt AJ; Sutherland RL
Adv Exp Med Biol; 2008; 617():445-51. PubMed ID: 18497068
[TBL] [Abstract][Full Text] [Related]
51. Analysis of CUL-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues.
Fay MJ; Longo KA; Karathanasis GA; Shope DM; Mandernach CJ; Leong JR; Hicks A; Pherson K; Husain A
Mol Cancer; 2003 Nov; 2():40. PubMed ID: 14641918
[TBL] [Abstract][Full Text] [Related]
52. [Distribution characteristic of NDRG2 expression in human fetal tissues.].
Hu XL; Yao LB; Zhang YQ; Deng YC; Liu XP
Sheng Li Xue Bao; 2006 Aug; 58(4):331-6. PubMed ID: 16906333
[TBL] [Abstract][Full Text] [Related]
53. Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue.
Schlott T; Eiffert H; Bohne W; Landgrebe J; Brunner E; Spielbauer B; Knight B
Gynecol Oncol; 2005 Sep; 98(3):409-19. PubMed ID: 16005053
[TBL] [Abstract][Full Text] [Related]
54. Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probe and the TaqMan technology.
Pinzani P; Orlando C; Raggi CC; Distante V; Valanzano R; Tricarico C; Maggi M; Serio M; Pazzagli M
Regul Pept; 2001 Jun; 99(2-3):79-86. PubMed ID: 11384768
[TBL] [Abstract][Full Text] [Related]
55. The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoter.
Zhang J; Li F; Liu X; Shen L; Liu J; Su J; Zhang W; Deng Y; Wang L; Liu N; Han W; Zhang J; Ji S; Yang A; Han H; Yao L
J Biol Chem; 2006 Dec; 281(51):39159-68. PubMed ID: 17050536
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of NDRG2 gene expression in primary papillary thyroid carcinoma and in metastases of this neoplasm to regional lymph nodes.
Mordalska A; Latek J; Ferenc T; Pomorski L; Gałecka E; Zygmunt A; Lewiński A
Thyroid Res; 2010 Aug; 3(1):6. PubMed ID: 20804549
[TBL] [Abstract][Full Text] [Related]
57. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
[TBL] [Abstract][Full Text] [Related]
58. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
59. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
[TBL] [Abstract][Full Text] [Related]
60. Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/β-catenin signaling.
Fu Q; Gao Y; Yang F; Mao T; Sun Z; Wang H; Song B; Li X
Biomed Pharmacother; 2018 Jan; 97():120-127. PubMed ID: 29080452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
